NDC 82570-005

Dexinling

Nattokinase Monascus Enzyme

Dexinling is a Topical Powder in the Human Otc Drug category. It is labeled and distributed by Shenzhen Deyintang Biotechnology Co., Ltd.. The primary component is Arginine; Collagen, Soluble, Fish Skin; Moringa Oleifera Leaf; Nattokinase; Red Yeast; Sesamin.

Product ID82570-005_d8826343-59d9-0f7b-e053-2a95a90aa8c0
NDC82570-005
Product TypeHuman Otc Drug
Proprietary NameDexinling
Generic NameNattokinase Monascus Enzyme
Dosage FormPowder
Route of AdministrationTOPICAL
Marketing Start Date2022-02-21
Marketing CategoryUNAPPROVED DRUG OTHER /
Labeler NameShenzhen Deyintang Biotechnology Co., Ltd.
Substance NameARGININE; COLLAGEN, SOLUBLE, FISH SKIN; MORINGA OLEIFERA LEAF; NATTOKINASE; RED YEAST; SESAMIN
Active Ingredient Strength20 g/100g; g/100g; g/100g; g/100g; g/100g; g/100g
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 82570-005-01

5 g in 1 POUCH (82570-005-01)
Marketing Start Date2022-02-21
NDC Exclude FlagN
Sample Package?N

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.